Compare, Analyse IPCA Labs with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    IPCA LABS
Mar-19
ADCOCK INGRAM
Jun-14
IPCA LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,042350-   
Low Rs590253-   
Sales per share (Unadj.) Rs298.6104.2-  
Earnings per share (Unadj.) Rs35.0-26.2-  
Cash flow per share (Unadj.) Rs49.4-21.8-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs247.181.8-  
Shares outstanding (eoy) m126.35168.78-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.72.9 94.4%   
Avg P/E ratio x23.3-11.5 -203.1%  
P/CF ratio (eoy) x16.5-13.9 -119.1%  
Price / Book Value ratio x3.33.7 89.6%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m103,10850,869 202.7%   
No. of employees `00013.44.3 313.1%   
Total wages/salary Rs m7,8743,193 246.6%   
Avg. sales/employee Rs Th2,807.04,095.3 68.5%   
Avg. wages/employee Rs Th585.8743.7 78.8%   
Avg. net profit/employee Rs Th329.0-1,031.9 -31.9%   
INCOME DATA
Net Sales Rs m37,73217,581 214.6%  
Other income Rs m577123 468.5%   
Total revenues Rs m38,30917,704 216.4%   
Gross profit Rs m6,901-3,047 -226.5%  
Depreciation Rs m1,824759 240.4%   
Interest Rs m189476 39.6%   
Profit before tax Rs m5,465-4,159 -131.4%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,042260 401.1%   
Profit after tax Rs m4,422-4,430 -99.8%  
Gross profit margin %18.3-17.3 -105.5%  
Effective tax rate %19.1-6.2 -305.3%   
Net profit margin %11.7-25.2 -46.5%  
BALANCE SHEET DATA
Current assets Rs m23,77812,877 184.7%   
Current liabilities Rs m10,9757,245 151.5%   
Net working cap to sales %33.932.0 105.9%  
Current ratio x2.21.8 121.9%  
Inventory Days Days104111 93.5%  
Debtors Days Days66124 53.2%  
Net fixed assets Rs m20,3687,506 271.4%   
Share capital Rs m25382 309.6%   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,22413,799 226.3%   
Long term debt Rs m1,4094,849 29.0%   
Total assets Rs m45,50726,068 174.6%  
Interest coverage x30.0-7.7 -387.5%   
Debt to equity ratio x00.4 12.8%  
Sales to assets ratio x0.80.7 122.9%   
Return on assets %10.1-15.2 -66.8%  
Return on equity %14.2-32.1 -44.1%  
Return on capital %17.3-19.8 -87.5%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,9231,501 328.0%  
From Investments Rs m-1,563-461 339.2%  
From Financial Activity Rs m-1,8324,401 -41.6%  
Net Cashflow Rs m1,5285,441 28.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.83 Rs / ZAR

Compare IPCA LABS With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: UNICHEM LAB  STRIDES PHARMA SCIENCE  LUPIN  SUN PHARMA  AJANTA PHARMA  



Today's Market

Sensex Ends 598 Points Lower, Nifty Settles Below 15,100-Mark; HDFC and JSW Steel Top Losers(Closing)

Indian share markets witnessed huge selling during closing hours today and ended their day deep in the red.

Related Views On News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

IPCA LABS SHARE PRICE


Mar 4, 2021 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS 5-YR ANALYSIS

COMPARE IPCA LABS WITH

FEATURED VIDEOS

Nifty is Weak but Smallcaps Can Outperform

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

More Featured Videos

MARKET STATS